Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A new study by Liverpool John Moores University scientists suggests that women using Hormone Replacement Therapy (HRT) to ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...